Trasylol Side Effects

Side effects like kidney failure and heart attack may result in injury lawsuits being filed by Trasylol patients. If you have been affected by the clotting drug, contact a Trasylol attorney for help.

The clotting drug Trasylol was removed from the market in 2007 at the FDA's request, due to serious concerns about the increased risk of life-threatening side effects among Trasylol patients. In fact, the FDA recall of Trasylol was initiated after the FDA was unable to find a population in which the possible benefits of Trasylol outweighed the potential risks. Trasylol (aprotinin) is a clotting drug used in patients undergoing open-heart surgery to prevent bleeding. The medication was approved by the FDA in 1993 and was manufactured by drug maker Bayer AG before it was pulled from the market worldwide fourteen years later. Although Trasylol is no longer on the market, Bayer continues to face litigation for serious side effects sustained by consumers who used the clotting drug prior to its suspension. If you took the pharmaceutical drug Trasylol and have since experienced a major side effect, contact a Trasylol attorney to discuss your legal options.

Life-Threatening Trasylol Side Effects

According to Trasylol side effect studies, patients who were administered the clotting drug during open-heart surgery may have an increased risk of suffering from potentially fatal side effects, including:

  • Kidney failure
  • Stroke
  • Heart attack
  • Death

A month before a failed Canadian Trasylol trial was begun, an FDA advisory panel recommended that the clotting drug remain on the market, despite mounting evidence that the medication may be linked to severe side effects. Experts have faulted the FDA for this decision, claiming that Trasylol should have been removed from the market in 2006 when a Journal of the American Medical Association study found an increased risk of kidney failure side effects in patients. According to the doctor who conducted this study, approximately 431,000 patients took Trasylol between the date of this study's publication and the date when Bayer finally pulled the drug from the market. According to this doctor's calculations, 22,000 lives could have been saved had the FDA taken quicker action against Bayer.

Trasylol Side Effect Studies and FDA Warnings

The FDA directed Trasylol maker, Bayer, to suspend sales of its clotting drug in November 2007, and Bayer began voluntarily removing the last stocks of the drug from the U.S. market in early 2008. This FDA decision was based on the results of a Canadian clinical trial, which was terminated early because researchers found that Trasylol patients were dying at a higher rate than others in the study. The intention of this trial was to show that Trasylol was more effective in controlling bleeding than other drugs of its kind, although the results actually indicated that the clotting drug increased the risk of death by 50%, compared to other drugs.

The year before this trial was conducted, a study was published in the JAMA, in which researchers found that Trasylol therapy increased the risk of kidney failure requiring dialysis in patients. Bayer's own Trasylol study actually confirmed these findings, and also determined that Trasylol could increase the risk of congestive heart failure, serious kidney damage and stroke among patients. In 2006, the FDA updated the Trasylol label to include a black box warning stating that the drug placed patients at a high risk of kidney failure and death. The year that Trasylol was removed from the market, two additional side effect studies were published, which indicated that Trasylol increased the long-term mortality of patients who had undergone bypass surgery, and that patients taking Trasylol had an increased risk of dying over the next five years than patients taking other medications.

Trasylol Attorneys for Side Effects

Since Trasylol entered the market in 1993, it has been used in one-third of all open-heart surgeries in the United States. If you or a loved one has experienced a serious side effect which you believe to be linked to Bayer's Trasylol, contact an experienced Trasylol attorney for legal help. You may have grounds to file a Trasylol lawsuit against Bayer in order to pursue financial compensation for your injuries, the medical cost of treating your injuries, and the pain and suffering endured by you and your family. You are not at fault for any injuries caused by a dangerous pharmaceutical drug, and you should not be held responsible for the resulting consequences. With the help of a qualified Trasylol lawyer, victims of potential Trasylol side effects can protect their rights and hold the allegedly negligent drug company liable for their injuries.





Prescription Drugs in The News